San Francisco Aims To Become Primary Gateway For Chinese Biotech Firms Expanding Across Pacific
This article was originally published in PharmAsia News
Executive Summary
BEIJING - San Francisco is stepping up its drive to become the North American headquarters for Chinese enterprises expanding across the Pacific and to attract life science firms based in the People's Republic to the Bay Area
You may also be interested in...
U.S. Economic Crisis, Beijing’s Perks, Could Trigger Reverse Brain Drain
BEIJING - The financial meltdown and widening layoffs in the United States, combined with Beijing's injection of stimulus funds into its pharmaceutical and biotech sectors, could trigger a reverse brain drain in those sectors, according to industry insiders and investors in the U.S. and China
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).